MedTrace Logo

Investigating Immune Mechanisms in Atopic Eczema

NCT02102841 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-04-30

No results posted yet for this study

Summary

The aim of this study is to investigate the mechanisms behind the immune dysfunction that occurs in atopic eczema (or atopic dermatitis).

Conditions

Interventions

PROCEDURE

Skin biopsy

PROCEDURE

Skin suction blister

BIOLOGICAL

Mantoux test

Sponsors & Collaborators

  • Dermatrust

    collaborator UNKNOWN

  • University College, London

    lead OTHER

Principal Investigators

  • Malcolm Rustin, MBBS MRCP MD · Royal Free London NHS Foundation Trust

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02102841 on ClinicalTrials.gov